Study: Many cancer drugs unproven 5 years after accelerated approval
The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives?
In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years.
“Five years after the initial accelerated approval, you should have a definitive answer,” said Dr. Ezekiel Emanuel, a cancer specialist and bioethicist at the University of Pennsylvania who was not involved in the research. “Thousands of people are getting those drugs. That seems a mistake if we don’t know whether they work or not.”
The program was created in 1992 to speed access to HIV drugs. Today, 85% of accelerated approvals go to cancer drugs.
It allows the FDA to grant early approval to drugs that show promising initial results for treating debilitating or fatal diseases. In exchange, drug companies are expected to do rigorous testing and produce better evidence before gaining full approval.
Related articles
- The 'real-life Martha' from Baby Reindeer bombarded Sir Keir Starmer with almost 300 emails, it has2024-05-21
Birds forage at beach in Kuwait City
A bird flies over the water in Kuwait City, Kuwait, Aug. 21, 2020. (Photo by Ghazy Qaffaf/Xinhua)2024-05-21Autumn scenery at Pofengling Scenic Area in Beijing
Aerial photo taken on Oct. 18, 2020 shows the autumn colors at Pofengling Scenic Area in Fangshan Di2024-05-21Spring scenery in Sichuan Fine Arts Institute in China's Chongqing
People enjoy spring scenery in Sichuan Fine Arts Institute in southwest China's Chongqing Municipali2024-05-21- Israel’s defense minister said Monday the military would expand its operations in the southern Gaza2024-05-21
Xi Sends Congratulatory Letter on 50th Anniversary of Cooperation Between China, WIPO
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-21
atest comment